Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension

By sjmartinez • October 11, 2022

Didriksen H, Molberg Ø, Mehta A, Jordan S, Palchevskiy V, Fretheim H, Gude E, Ueland T, Brunborg C, Garen T, Midtvedt Ø, Andreassen AK, Lund-Johansen F, Distler O, Belperio J, Hoffmann-Vold AM. Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension. Front Immunol. 2022 Sep 23;13:991743. doi: 10.3389/fimmu.2022.991743. PMID: 36211384; PMCID: PMC9541617.

Tags: Anti-CCL21, CCL21, ELISA Enzyme-linked immunosorbent assay, Luminex (xMAP) method, Publications, pulmonary arteria hypertension, Pulmonary, Critical Care & Sleep Medicine, systemic sclerosis

Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment

Guo J, Kostrzyńska K, Kamzolas I, Yang X, Thorikay M, De Bie E, Jones RJ, Brownstein A, Long L, Rhodes CJ, Lawrie A, Wilkins MR,[...]

Temporal Trends in Incidence and Prevalence of Heart Failure Hospitalization Among Medicare Beneficiaries

Mentias A, Keshvani N, Desai MY, Fonarow GC, Teerlink JR, Thibodeau JT, Vest AR, Pandey A. Temporal Trends in Incidence and Prevalence of Heart Failure[...]

Temporal Trends in Heart Failure and Stroke-Related Mortality in the United States, 1999-2023

Bilal AR, Sajid M, Qureshi S, Gaba H, Ahmad R, Alta'amreh M, Ahmed R, Amin MHJ, Fonarow GC, Waqas SA. Temporal Trends in Heart Failure[...]